Euclidean Capital
NEW YORK, NYfiles as Euclidean Capital LLC
$440m in 11 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 2.1% of the portfolio this quarter.
Value
$440m
Stocks
11
Top 10 share
100.0%
Turnover
2.1%
What changed this quarter
New
Bought for the first time this quarter.
- TeamsharesTMS2.1% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
- Vanguard Intl Equity Index FVEU
- Share
- 61.8%
- Value
- $272m
- Shares
- 3,243,484
Held
- Vanguard Index FDSVTV
- Share
- 25.8%
- Value
- $113m
- Shares
- 520,000
Held
- Ishares TRINDA
- Share
- 4.2%
- Value
- $18m
- Shares
- 369,600
Held
- Surrozen
- Share
- <0.1%
- Value
- $2,819
- Shares
- 170,833
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Vanguard Intl Equity Index FVEU | 61.8% | $272m | 3,243,484 | Held |
| Vanguard Index FDSVTV | 25.8% | $113m | 520,000 | Held |
| Ishares TRINDA | 4.2% | $18m | 369,600 | Held |
| Oric PharmaceuticalsORIC | 2.4% | $11m | 989,410 | Held |
| TeamsharesTMS | 2.1% | $9m | 1,099,974 | New |
| Foghorn TherapeuticsFHTX | 1.7% | $8m | 1,573,761 | Held |
| PMV PharmaceuticalsPMVP | 0.8% | $4m | 2,627,643 | Held |
| AlectorALEC | 0.6% | $3m | 1,307,858 | Held |
| SurrozenSRZN | 0.5% | $2m | 87,696 | Held |
| Tenaya TherapeuticsTNYA | 0.2% | $750,708 | 1,015,705 | Held |
| Surrozen | <0.1% | $2,819 | 170,833 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 43.9% since 30 June 2025.
Where the money is
Health care6.3%
Retail & consumer2.1%
Other91.7%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.